-

Milliman analysis: Corporate pension funded status continues to climb, hits 104.9% at end of February

Rising discount rates offset bond underperformance for Milliman 100 PFI plans

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the results of its latest Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.

During February, the Milliman 100 PFI funded ratio rose from 102.8% at the end of January to 104.9% as of February 29. A second straight month of rising discount rates—which increased in February by 21 basis points, to 5.35%—drove the improvement and reduced plan liabilities by $30 billion. This helped to offset the plans’ February investment performance. Market declines, primarily in fixed income, led to nearly flat monthly returns of 0.12% and caused the market value of PFI plan assets to fall $4 billion to $1.349 trillion at the end of February.

“After discount rates dropped significantly at the end of 2023, the past two months of rising rates and corresponding funded status gains have added to the PFI plans’ funding surplus,” said Zorast Wadia, author of the PFI. “However, with expectations of rate cuts later in the year, it’s possible these gains may be short-lived unless plan sponsors adhere to matching asset-liability strategies to control rate volatility.”

Looking forward, under an optimistic forecast with rising interest rates (reaching 5.85% by the end of 2024 and 6.45% by the end of 2025) and asset gains (9.8% annual returns), the funded ratio would climb to 116% by the end of 2024 and 130% by the end of 2025. Under a pessimistic forecast (4.85% discount rate at the end of 2024 and 4.25% by the end of 2025 and 1.8% annual returns), the funded ratio would decline to 97% by the end of 2024 and 88% by the end of 2025.

To view the complete Pension Funding Index, go to www.milliman.com/pfi. To see Milliman’s full range of annual Pension Funding Studies, go to https://www.milliman.com/en/retirement-and-benefits/pension-funding-studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman is among the world's largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. For further information, visit milliman.com.

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

Milliman, Inc.


Release Summary
Milliman has just released the latest results of its Corporate Pension Funding Index.
Release Versions

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom